Effect of troglitazone on the proinsulin level in patients with type 2 diabetes mellitus: A pilot study
- 30 June 1999
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 60 (6) , 349-356
- https://doi.org/10.1016/s0011-393x(99)80011-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Thiazolidinediones in the treatment of insulin resistance and type II diabetesDiabetes, 1996
- Effect of Combination Therapy of Troglitazone and Sulphonylureas in Patients with Type 2 Diabetes Who Were Poorly Controlled by Sulphonylurea Therapy AloneDiabetic Medicine, 1996
- Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapyDiabetes Care, 1996
- Improved Beta Cell Function, with Reduction in Secretion of Intact and 32/33 Split Proinsulin, after Dietary Intervention in Subjects with Type 2 Diabetes MellitusDiabetic Medicine, 1994
- Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic ratsDiabetes, 1993
- Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overviewDiabetologia, 1992
- The relationships of concentrations of insulin, intact proinsulin and 32?33 split proinsulin with cardiovascular risk factors in Type 2 (non-insulin-dependent) diabetic subjectsDiabetologia, 1990
- Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDMDiabetes, 1989
- Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistanceDiabetologia, 1987
- Measurement of circulating human proinsulin concentrations using a proinsulin-specific antiserumDiabetes, 1985